1.9500
-0.0800
(-3.94%)
At close: January 10 at 4:00:00 PM EST
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-5,880.1390
-5,880.1390
-2,595.1950
-3,147.7930
-4,078.7470
Operating Cash Flow
-2,937.6700
--
--
--
--
Investing Cash Flow
327.5610
327.5610
-2,621.2790
11.7370
2.5740
Financing Cash Flow
0.8290
0.8290
-44.6670
-42.4480
26,480.1820
End Cash Position
11,657.3150
11,657.3150
17,159.7640
22,110.2780
25,047.2810
Capital Expenditure
-0.1950
-0.1950
-7.7390
-10.0480
-6.6300
Issuance of Capital Stock
24.0000
24.0000
--
--
29,281.4210
Issuance of Debt
--
--
--
--
212.7940
Repayment of Debt
-15.5950
-15.5950
-35.0150
-36.2640
-253.4010
Free Cash Flow
-5,880.3340
-5,880.3340
-2,602.9340
-3,157.8410
-4,085.3770
6/30/2021 - 6/9/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TELI.CN Telescope Innovations Corp.
0.3900
+2.63%
TELIF Telescope Innovations Corp.
0.2900
-0.07%
TNGX Tango Therapeutics, Inc.
2.9250
-9.44%
DWTX Dogwood Therapeutics, Inc.
2.3600
-3.67%
KAPA Kairos Pharma, Ltd.
0.9700
-5.83%
ATHE Alterity Therapeutics Limited
3.3400
0.00%
OCEA Ocean Biomedical, Inc.
0.6318
-5.43%
RLYB Rallybio Corporation
0.9400
-5.63%
CMMB Chemomab Therapeutics Ltd.
2.1200
-4.50%
CSBR Champions Oncology, Inc.
9.47
-1.97%